Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Po-Hong Liu

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Plos One|March 24, 2017
Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspectiveYu-Wen Su, Po-Hong Liu, Chia-Yang Hsu, et al.
Digestive Diseases and Sciences|January 20, 2020
Differential Survival Impact of Diabetes Mellitus on Hepatocellular Carcinoma: Role of Staging DeterminantsShu-Yein Ho, Mei-Hsia Yuan, Chu-Chieh Chen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 3, 2018
Metastasis in patients with hepatocellular carcinoma: Prevalence, determinants, prognostic impact and ability to improve the Barcelona Clinic Liver Cancer systemChia-Yang Hsu, Po-Hong Liu, Shu-Yein Ho, et al.
Plos One|March 5, 2015
Using serum α-fetoprotein for prognostic prediction in patients with hepatocellular carcinoma: what is the most optimal cutoff?Chia-Yang Hsu, Po-Hong Liu, Yun-Hsuan Lee, et al.
Journal of Clinical Gastroenterology|February 25, 2015
Active Treatments Prolong the Survival in Patients With Hepatocellular Carcinoma and Performance Status 3 or 4: A Propensity Score AnalysisChia-Yang Hsu, Po-Hong Liu, Yun-Hsuan Lee, et al.
Scientific Reports|August 13, 2017
A New Treatment-integrated Prognostic Nomogram of the Barcelona Clinic Liver Cancer System for Hepatocellular CarcinomaChia-Yang Hsu, Po-Hong Liu, Cheng-Yuan Hsia, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2016
Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patientsPo-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, et al.
Plos One|March 4, 2014
Decrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score modelChia-Yang Hsu, Yun-Hsuan Lee, Po-Hong Liu, et al.
Gastroenterology|August 26, 2018
Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health StudyKristin E Burke, Ashwin N Ananthakrishnan, Paul Lochhead, et al.
Journal of Gastrointestinal Cancer|May 31, 2022
Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysisGauri Mishra, Ammar Majeed, Anouk Dev, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Plos One|March 24, 2017
Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspectiveYu-Wen Su, Po-Hong Liu, Chia-Yang Hsu, et al.
Digestive Diseases and Sciences|January 20, 2020
Differential Survival Impact of Diabetes Mellitus on Hepatocellular Carcinoma: Role of Staging DeterminantsShu-Yein Ho, Mei-Hsia Yuan, Chu-Chieh Chen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 3, 2018
Metastasis in patients with hepatocellular carcinoma: Prevalence, determinants, prognostic impact and ability to improve the Barcelona Clinic Liver Cancer systemChia-Yang Hsu, Po-Hong Liu, Shu-Yein Ho, et al.
Plos One|March 5, 2015
Using serum α-fetoprotein for prognostic prediction in patients with hepatocellular carcinoma: what is the most optimal cutoff?Chia-Yang Hsu, Po-Hong Liu, Yun-Hsuan Lee, et al.
Journal of Clinical Gastroenterology|February 25, 2015
Active Treatments Prolong the Survival in Patients With Hepatocellular Carcinoma and Performance Status 3 or 4: A Propensity Score AnalysisChia-Yang Hsu, Po-Hong Liu, Yun-Hsuan Lee, et al.
Scientific Reports|August 13, 2017
A New Treatment-integrated Prognostic Nomogram of the Barcelona Clinic Liver Cancer System for Hepatocellular CarcinomaChia-Yang Hsu, Po-Hong Liu, Cheng-Yuan Hsia, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2016
Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patientsPo-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, et al.
Plos One|March 4, 2014
Decrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score modelChia-Yang Hsu, Yun-Hsuan Lee, Po-Hong Liu, et al.
Gastroenterology|August 26, 2018
Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health StudyKristin E Burke, Ashwin N Ananthakrishnan, Paul Lochhead, et al.
Journal of Gastrointestinal Cancer|May 31, 2022
Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysisGauri Mishra, Ammar Majeed, Anouk Dev, et al.
Pageof 9